DiOC2(3) is not a substrate for multidrug resistance protein (MRP)-mediated drug efflux.
about
Histone methyltransferase MLL1 regulates MDR1 transcription and chemoresistanceSensitive and specific fluorescent probes for functional analysis of the three major types of mammalian ABC transportersOral cyclosporin A inhibits CD4 T cell P-glycoprotein activity in HIV-infected adults initiating treatment with nucleoside reverse transcriptase inhibitorsKinetic analysis of rhodamines efflux mediated by the multidrug resistance protein (MRP1)Modulation of the cellular accumulation and intracellular activity of daptomycin towards phagocytized Staphylococcus aureus by the P-glycoprotein (MDR1) efflux transporter in human THP-1 macrophages and madin-darby canine kidney cells.Cannabidiol changes P-gp and BCRP expression in trophoblast cell linesABC transporters in human lymphocytes: expression, activity and role, modulating factors and consequences for antiretroviral therapies.Cytometric assessment of mitochondria using fluorescent probes.Nature and uses of fluorescent dyes for drug transporter studies.A photoactivatable drug-caged fluorophore conjugate allows direct quantification of intracellular drug transport.Salmonella enterica serovar Typhimurium modulates P-glycoprotein in the intestinal epithelium.The medicinal plant goldenseal is a natural LDL-lowering agent with multiple bioactive components and new action mechanisms.Chromatin-Remodeling Complex SWI/SNF Controls Multidrug Resistance by Transcriptionally Regulating the Drug Efflux Pump ABCB1.A distinct subset of self-renewing human memory CD8+ T cells survives cytotoxic chemotherapy.Neither lipophilicity nor membrane-perturbing potency of phenothiazine maleates correlate with the ability to inhibit P-glycoprotein transport activity.Involvement of adenosine triphosphate-binding cassette subfamily B member 1 in the augmentation of triacylglycerol excretion by Propionibacterium acnes in differentiated hamster sebocytes.Is modulation of multidrug resistance a viable strategy for acute myeloid leukemia?
P2860
Q24300652-1A3E5AD6-EF11-42D8-99A0-D1B02C30134CQ28479253-826B2159-F9A8-4DF0-9708-0B8D09302F05Q33864976-CE7AA192-8367-417C-9F59-8264300FB25DQ34182790-5CA15C62-A766-4D47-98F8-E5D0BAFBDCF4Q35912731-2CA2A6DC-C29E-4815-AA81-893C81B83E2CQ37178591-23712050-38F0-445C-BF66-F3D454306DA6Q37724178-0B3000C0-F8CF-4DC5-AA17-F896CCF101DCQ37877220-2FFD21F7-5D4B-4D83-8283-B619A77C1A25Q38518912-01974557-8532-4886-8397-6286AA2E9AE8Q39077308-DFB16D64-3EBB-4EA0-92CC-FD9DEF3E6383Q39993149-AC724BDB-93B6-4B52-9A60-1F34938F79D8Q40248401-EC22CA12-7F7F-47AD-80C2-C28802CDEACCQ41636714-9AED402F-28EE-4A05-BBB0-1EAE8544611FQ42169041-D44EF963-C675-4CE4-8741-D84FE38F38C4Q44440276-973AFB05-20E2-4F48-9953-DEAABE554FDEQ47822271-AE17A385-BC89-4885-B126-D18B18DAA2B4Q59315439-C8954257-0AF8-4FF4-82FF-E72EFA257B8E
P2860
DiOC2(3) is not a substrate for multidrug resistance protein (MRP)-mediated drug efflux.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
DiOC2(3) is not a substrate for multidrug resistance protein (MRP)-mediated drug efflux.
@en
type
label
DiOC2(3) is not a substrate for multidrug resistance protein (MRP)-mediated drug efflux.
@en
prefLabel
DiOC2(3) is not a substrate for multidrug resistance protein (MRP)-mediated drug efflux.
@en
P2093
P2860
P1433
P1476
DiOC2(3) is not a substrate for multidrug resistance protein (MRP)-mediated drug efflux.
@en
P2093
Minderman H
Minderman MD
Vanhoefer U
P2860
P356
10.1002/(SICI)1097-0320(19960901)25:1<14::AID-CYTO2>3.0.CO;2-E
P577
1996-09-01T00:00:00Z